Styrax Pharma Private Limited - Company Profile

It is a pharma private limited company based in Vishakapatnam, Andhra Pradesh, India, established in 1995.
1995 Vishakapatnam, Andhra Pradesh, India Active
Last Updated:
Access Report
About Styrax Pharma Private Limited

Styrax Pharma Private Limited, a active private limited company, was established on 10 July 1995 in Vishakapatnam, Andhra Pradesh, India. Engaging in api manufacturers within the manufacturing sector, it holds CIN: U24230AP1995PTC098146. Registered under ROC Roc Vijayawada. it is unlisted. It has an authorized capital of ₹15.00 Cr and a paid-up capital of ₹13.12 Cr.

Formerly known as Vaya Jayanthi Drugs Private Limited. It upholds a compliant status. Employing 260 professional, Its leadership includes Sreenath Suryadevara (Director), Lakshmi Devi Suryadevara (Director), Suryadevara Venkateswara Rao (Managing Director). Past directors included Viswanadha Raju Penmatsa, Sreenath Suryadevara, Lakshmi Devi Suryadevara. It holds ₹187.82 Cr open charges and ₹163.68 Cr settled loans. Its latest AGM occurred on 29 September 2025, with the balance sheet filed on 31 March 2025. It is based at Plot No. 27B J. N. Pharmacity, Parawada, Vishakapatnam, Vishakapatnam, Andhra Pradesh, 531021.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24230AP1995PTC098146

  • Registration Number

    098146

  • Incorporation Date

    10 July 1995

  • Authorized Capital

    ₹15.00 Cr

  • Paid-Up Capital

    ₹13.12 Cr

  • ROC Code

    Roc Vijayawada

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 15.00 Cr
  • Paid Up Capital ₹ 13.12 Cr
  • Company Age 30 Year, 7 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 187.82 Cr
  • Satisfied Charges ₹ 163.68 Cr
  • Revenue Growth **** -6.19%
  • Profit Growth **** 1.69%
  • Ebitda **** -12.20%
  • Net Worth 16.41%
  • Total Assets -4.38%
Company report

Styrax Pharma Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Styrax Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Styrax Pharma Private Limited?
Current Directors
Name Designation Appointment Date Status
Sreenath Suryadevara Director 18 Apr 2019 Current
Lakshmi Devi Suryadevara Director 18 Apr 2019 Current
Suryadevara Venkateswara Rao Managing Director 23 Jun 2014 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 23 May 2014 Past
Pramod Abcsdd Additional Director 30 Sep 2019 Past
Pramod Abcsdd Director 25 Jul 2017 Past
Pramod Abcsdd Managing Director 01 Apr 2008 Past
Pramod Abcsdd Director 06 Nov 2014 Past
Pramod Abcsdd Director 21 Sep 2015 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Styrax Pharma.

Styrax Pharma Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 6.19% decrease. The company also saw a slight improvement in profitability, with a 1.69% increase in profit. The company's net worth Soared by an impressive increase of 16.41%.

Styrax Pharma revenue growth over time
Styrax Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 -6.19%
*******
*******
*******
*******
Revenue from Operations
*******
 -5.77%
*******
*******
*******
*******
Total Assets
*******
 -4.38%
*******
*******
*******
*******
Profit or Loss
*******
 1.69%
*******
*******
*******
*******
Net Worth
*******
 16.41%
*******
*******
*******
*******
EBITDA
*******
 -12.20%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Styrax Pharma?

In 2023, Styrax Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹1,878,161,681.00

Satisfied Charges

₹1,636,830,743.00

Charges Breakdown by Lending Institutions
  • Others : 80.00 Cr
  • Hdfc Bank Limited : 64.90 Cr
  • Yes Bank Limited : 21.50 Cr
  • Axis Bank Limited : 21.42 Cr
Latest Charge Details
Date Lender Amount Status
04 Oct 2023 Others ₹45.00 Cr Open
29 Mar 2023 Yes Bank Limited ₹1.50 Cr Open
29 Mar 2023 Yes Bank Limited ₹20.00 Cr Open
23 Mar 2023 Axis Bank Limited ₹20.80 Cr Open
01 Mar 2023 Others ₹35.00 Cr Open

Explore comprehensive loan charge details -

How Many Employees Work at Styrax Pharma?

Styrax Pharma has a workforce of 260 employees as of Dec 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Styrax Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Styrax Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Styrax Pharma
Recent Activity within the Organization
  • Annual General Meeting

    The activity Styrax Pharma Private Limited last Annual general meeting of members was held on 29 Sep 2025 as per latest MCA records. was completed.

  • Charges

    A charge with Others of Rs. 35.00 Cr registered on 01 Mar 2023 with Charge ID 100682072 was modified on 23 Apr 2025. was recorded as a recent event.

  • Balance Sheet

    The activity Styrax Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Vijayawada. was completed.

  • Charges

    A charge registered on 17 Jul 2023 via Charge ID 100749047 with Others was fully satisfied on 28 Mar 2025. was recorded as a recent event.

  • Charges

    A charge with Others of Rs. 45.00 Cr registered on 04 Oct 2023 with Charge ID 100803552 was modified on 29 Nov 2024. was recorded as a recent event.

  • Charges

    The activity A charge registered on 31 Mar 2021 via Charge ID 100440801 with Others was fully satisfied on 16 Oct 2024. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Styrax Pharma Private Limited?

The CIN of Styrax Pharma Private Limited is U24230AP1995PTC098146.

Where is Styrax Pharma Private Limited headquartered?

Styrax Pharma Private Limited is headquartered at Plot No. 27B J. N. Pharmacity, Parawada, Vishakapatnam, Vishakapatnam, Andhra Pradesh, 531021.

When was Styrax Pharma Private Limited incorporated?

Styrax Pharma Private Limited was incorporated on 10 July 1995.

Who are the current directors of Styrax Pharma Private Limited?

The current directors of Styrax Pharma Private Limited are

What is the primary industry of Styrax Pharma Private Limited?

The primary industry of Styrax Pharma Private Limited is Manufacturing.

Is Styrax Pharma Private Limited a listed company?

Styrax Pharma Private Limited is unlisted.

What is the capital structure of Styrax Pharma Private Limited?

The authorized capital of Styrax Pharma Private Limited is ₹15.00 Cr, and the paid-up capital is ₹13.12 Cr.

What is the compliance status of Styrax Pharma Private Limited?

The compliance status of Styrax Pharma Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available